Anlon Healthcare Limited (NSE:AHCL)
India · Delayed Price · Currency is INR 14.61
+0.09 (0.62%)
At close: Jul 31, 2026
Anlon Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 2,262 | 1,720 | 1,203 | 665.84 | 1,129 | 571.43 |
Other Revenue | 0.48 | - | 0.47 | 0.33 | 2.02 | 2.46 |
| 2,263 | 1,720 | 1,203 | 666.16 | 1,131 | 573.89 | |
Revenue Growth | 95.41% | 42.91% | 80.64% | -41.09% | 97.04% | 259.14% |
Cost of Revenue | 1,470 | 1,051 | 752.26 | 348.75 | 888.76 | 438.05 |
Gross Profit | 793.2 | 668.65 | 451.07 | 317.42 | 242.04 | 135.84 |
Selling, General & Admin | 62.62 | 55.4 | 65.86 | 62.45 | 42.51 | 32.59 |
Other Operating Expenses | 161.43 | 138.08 | 57.57 | 97.34 | 68.22 | 44.62 |
Operating Expenses | 245.68 | 208.72 | 141.18 | 178.66 | 129.39 | 95.64 |
Operating Income | 547.52 | 459.93 | 309.9 | 138.75 | 112.65 | 40.2 |
Interest Expense | -38.45 | -37.41 | -37.7 | -40.77 | -37.89 | -41.06 |
Interest & Investment Income | - | - | 0.81 | 0.76 | - | - |
Currency Exchange Gain (Loss) | - | - | -1.3 | -0.32 | -3.82 | -0.07 |
Other Non Operating Income (Expenses) | 2.55 | 2.55 | -2.78 | -0.92 | -1.01 | -0.15 |
EBT Excluding Unusual Items | 511.63 | 425.07 | 268.94 | 97.51 | 69.93 | -1.08 |
Gain (Loss) on Sale of Assets | - | - | -0.06 | - | - | - |
Pretax Income | 511.63 | 425.07 | 268.88 | 97.51 | 69.93 | -1.08 |
Income Tax Expense | 173.4 | 134.19 | 63.7 | 0.94 | 11.73 | - |
Earnings From Continuing Operations | 338.23 | 290.88 | 205.18 | 96.57 | 58.2 | -1.08 |
Minority Interest in Earnings | -21.94 | -5.74 | - | - | - | - |
Net Income | 316.29 | 285.14 | 205.18 | 96.57 | 58.2 | -1.08 |
Net Income to Common | 316.29 | 285.14 | 205.18 | 96.57 | 58.2 | -1.08 |
Net Income Growth | 55.80% | 38.97% | 112.46% | 65.93% | - | - |
Shares Outstanding (Basic) | 472 | 467 | 322 | 145 | 120 | 120 |
Shares Outstanding (Diluted) | 472 | 467 | 322 | 145 | 120 | 120 |
Shares Change | - | 44.80% | 123.02% | 20.43% | - | -0.05% |
EPS (Basic) | 0.67 | 0.61 | 0.64 | 0.67 | 0.48 | -0.01 |
EPS (Diluted) | 0.67 | 0.61 | 0.64 | 0.67 | 0.48 | -0.01 |
EPS Growth | - | -4.02% | -4.70% | 37.73% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -1,159 | -230.81 | -67.58 | -32.22 | -22.32 |
Free Cash Flow Per Share | - | -2.48 | -0.72 | -0.47 | -0.27 | -0.19 |
Gross Margin | 35.05% | 38.88% | 37.48% | 47.65% | 21.40% | 23.67% |
Operating Margin | 24.20% | 26.75% | 25.75% | 20.83% | 9.96% | 7.00% |
Profit Margin | 13.98% | 16.58% | 17.05% | 14.50% | 5.15% | -0.19% |
Free Cash Flow Margin | - | -67.37% | -19.18% | -10.14% | -2.85% | -3.89% |
EBITDA | 562.31 | 475.17 | 327.64 | 157.63 | 131.31 | 58.62 |
EBITDA Margin | 24.85% | 27.63% | 27.23% | 23.66% | 11.61% | 10.21% |
D&A For EBITDA | 14.78 | 15.24 | 17.74 | 18.88 | 18.66 | 18.42 |
EBIT | 547.52 | 459.93 | 309.9 | 138.75 | 112.65 | 40.2 |
EBIT Margin | 24.20% | 26.75% | 25.75% | 20.83% | 9.96% | 7.00% |
Effective Tax Rate | 33.89% | 31.57% | 23.69% | 0.96% | 16.78% | - |
Revenue as Reported | 2,265 | 1,722 | 1,205 | 666.92 | 1,131 | 575.36 |
Advertising Expenses | - | - | 0.07 | - | - | - |